Work

Phase I Study of the Novel Surivin and cdc2/CDK1 Inhibitor Terameprocol in Patients with Advanced Leukemias.

Year: 2009

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v114.22.1039.1039

Authors: Raoul Tibes, Kevin T. McDonagh, Lazaros Lekakis, Neal Frazer, Scott Mohrland, Bassett Dawn, Reynaldo Garcia, Katy Schroeder, Vijayalakshmi Shanmugam, John Carpten, Daniel Von Hoff, Thomas C. Shea

Institutions: Translational Genomics Research Institute, University of Kentucky, Markey Cancer Center, University of North Carolina at Chapel Hill

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2550344164

FWCI: 1.188

Cites:

Cited by: 10

Related to: 10